Company Data

Centessa Pharmaceuticals plc

Ticker
CNTA
Current Price
$15.58 -2.07%
Market Cap
$2.1B
Price Target
Refer to Report
Volume
114.4K
52wk Range
$7.75 - $19.09
Advanced Market Data

Overview

Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy